Lung Cancer Tumorigenicity and Drug Resistance Are Maintained Through ALDHhi CD44hi Tumor Initiating Cells

Oncotarget - United States
doi 10.18632/oncotarget.1246
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

NRP1-positive Lung Cancer Cells Possess Tumor-Initiating Properties

Oncology Reports
MedicineCancer ResearchOncology
2017English

Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Drug Resistance in Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Cancer Stem Cells and Escape From Drug-Induced Premature Senescence in Human Lung Tumor Cells: Implications for Drug Resistance and in Vitro Drug Screening Models

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Cancer Stem Cells, Plasticity, and Drug Resistance

2020English

Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Cancer Research
Cancer ResearchOncology
2011English

Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2015English

Identification of Cancer Initiating Cells in K-Ras Driven Lung Adenocarcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Gossypol Induces Apoptosis by Activating P53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy